Dolby Laboratories, Inc.
DLB
$70.67
-$1.30-1.81%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.26% | 537.60% | 134.43% | 2.23% | -15.61% |
| Total Depreciation and Amortization | 20.21% | 0.52% | -12.74% | -15.51% | -6.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.35% | -53.51% | -55.65% | 61.47% | 19.92% |
| Change in Net Operating Assets | 87.32% | 121.19% | -206.38% | 210.55% | -59.24% |
| Cash from Operations | 1,169.82% | 36.65% | -82.45% | 73.53% | -85.09% |
| Capital Expenditure | -11.15% | 9.85% | -2.70% | -18.50% | 15.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 2,129.74% | -103.50% | -128.79% | -81.05% |
| Cash from Investing | -1,386.10% | -1,225.70% | -135.15% | -175.78% | -97.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.47% | -93.21% | -35.96% | 5.79% | 73.66% |
| Repurchase of Common Stock | 58.59% | 21.35% | -35.63% | 48.73% | -53.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.49% | -10.78% | -11.07% | -10.99% | -10.37% |
| Other Financing Activities | 29.32% | -- | -- | -- | -36.68% |
| Cash from Financing | 53.99% | -40.47% | -58.57% | 34.18% | -38.90% |
| Foreign Exchange rate Adjustments | -205.48% | 218.52% | -43.79% | -503.62% | -20.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.02% | -1,168.07% | -143.25% | 86.78% | -3,619.25% |